Allergan, Inc.

Submit Your Information

Company Name	Allergan, Inc.
Stock Symbol	AGN
Class Period	February 25, 2014 to April 21, 2014
Lead Plaintiff Motion Deadline	February 16, 2015
Court	USDC Central District of California

The Firm is investigating potential claims on behalf of persons who sold the common stock of Allergan, Inc. (NYSE:AGN) between February 25, 2014 and April 21, related to alleged violations of federal securities laws by Valeant Pharmaceuticals International, Inc. and Pershing Square Capital Management L.P., among others. Investors who have losses of $100,000 or more are encouraged to contact the firm for more information.

Submit Your Information

If you suffered a loss on your Allergan, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

First Name*

Middle Initial

Last Name*

Email*

Phone*

If representing a Corporation, Trust, Partnership or other entity, Name of Entity

If representing an Entity, Position at Entity

Mailing Address

City

State/Province

ZIP/Postal Code

Country

Are you a current or former employee of the company?

Did you purchase any shares before February 25, 2014?

Shares Purchased

Number of Shares	Buy Date	Price Per Share	Add
Purchased quantity	Purchased month Purchased day Purchased year

Shares Sold

Number of Shares	Sell Date	Price Per Share	Add
	Sold month Sold day Sold year

Additional Comments